Results 241 to 250 of about 6,718,803 (257)

Canakinumab for the treatment of adult-onset Still’s disease

Expert Review of Clinical Immunology, 2020
Paolo Sfriso, Andrea Doria, Paola Galozzi   +2 more
exaly  

Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease

Rheumatology, 2022
Annamaria Iagnocco, Silvia Balduzzi, Luisa Costa   +2 more
exaly  

Adult-onset Still's disease—pathogenesis, clinical manifestations, and new treatment options

Annals of Medicine, 2015
Petros Efthimiou, Sabeeda Kadavath
exaly  

Cyclosporin A treatment for Japanese patients with severe adult-onset Still’s disease

Modern Rheumatology, 2009
Syuichi Koarada, Yoshifumi Tada, Kohei Nagasawa   +2 more
exaly  

Tocilizumab for the treatment of adult-onset Still’s disease

Expert Opinion on Biological Therapy, 2019
Belén Atienza-Mateo, Santos Castañeda
exaly  

Biologic drugs in adult onset Still’s disease: a systematic review and meta-analysis of observational studies

Expert Review of Clinical Immunology, 2017
Francesco Ursini, Paola Cipriani, Roberto Giacomelli   +2 more
exaly  

A comprehensive review on adult onset Still's disease

Journal of Autoimmunity, 2018
Roberto Giacomelli, Yehuda Shoenfeld, Piero Ruscitti   +2 more
exaly  

Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome

Modern Rheumatology, 2011
Hiroyuki Yamashita, Yuko Takahashi, Akio Mimori   +2 more
exaly  

Anakinra for the treatment of adult-onset Still’s disease

Expert Review of Clinical Immunology, 2018
Belén Atienza-Mateo, Santos Castañeda
exaly  

Pathogenesis of adult onset still’s disease: current understanding and new insights

Expert Review of Clinical Immunology, 2018
Roberto Giacomelli, Piero Ruscitti
exaly